Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2026-01-04 @ 12:27 AM
Study NCT ID:
NCT06603558
Status:
RECRUITING
Last Update Posted:
2025-04-10
First Post:
2024-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine
Sponsor:
AbbVie
Organization:
Conditions & Keywords Data
Conditions: